Aldosterone antagonists: silver bullet or just sodium excretion and potassium retention?
Related Research units
Abstract
ACE inhibitors or AT(1) antagonists are powerful therapeutic strategies to slow the progression of renal disease. However, they provide only imperfect protection since they cannot always prevent end-stage renal failure. Innovative approaches are needed to keep patients with chronic kidney disease off dialysis. Blockade of the aldosterone pathway may prove to be such a beneficial therapeutic concept.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 5 |
| ISSN | 0085-2538 |
| Publication status | Published - 2007 |
| pubmed | 17315004 |
|---|
